Petros Thomakos INTERNIST

• “Effect of smoking on function of autonomic nervous system of the heart in patients with Type 2 Diabetes Mellitus” (Athens University Medical School – 2013). 

• 25/06/2003: Registration to the Athens Medical Council (Registration no: 054480).
• 26/03/2010: Registration as a Medical Practitioner with Specialist Registration to the General Medical Council (Registration no: 7066468).
• 2003: Member of the European Group for the Study of Insulin Resistance (EGIR).
• 2006: Member of the European Association for the Study of Diabetes (EASD). 
• 2007: Member of the Hellenic Society for Infectious Diseases.
• 2007: Member of the Hellenic Society for the Study of Diabetic Foot.
• 2008: Member of the Hellenic Society of Diabetology.
• 2008: Member of the Hellenic Society for Neuroendocrine tumors.
• 2011: Member of the Hellenic Association for Obesity, Metabolism and Endocrinology Disorders (HASHOMED)

Editorial Boards:
AD-HOC REVIEWER for peer-reviewed international journals

• Postgraduate Medical Journal, Journal of Diabetes Research, Diabetology & Metabolic Syndrome

• 1/07/2013 – now: Consultant in Internal Medicine and Diabetes at Hygeia Hospital Athens Greece (Director Dr Christos Zoupas) 
• 16/11/2009 – 31/08/2013: Clinical Research Associate in the department of Diabetes and Nutritional Sciences within the School of Medicine at King’s College London (Director Professor Stephanie Amiel). 
• 01/05/2010 – 31/08/2013: Honorary Specialist Registrar in the department of Diabetes at King’s College Hospital (Responsible to Prof. Stephanie Amiel and Dr. David Hopkins).
• 10/03/2009 – 13/11/2009: Clinical Research Fellow in the Diabetes Centre of the First Department of Propaedeutic and Internal Medicine of the Laikon General Hospital – Athens Greece. (Director Associate Professor N. Tentolouris).
• 09/03/2004 – 09/03/2009: Specialist Registrar in Internal Medicine, A’ Propaedeutic University Clinic of Internal Medicine, “Laikon Hospital” – Athens Greece. (Director Professor N. Katsilambros and Professor S. Ladas). 
• 13/01/2003 – 08/03/2004: Research fellow in Diabetes and Metabolism Unit, “Henry Dunant” General Hospital – Athens Greece. (Director Professor A. Mitrakou).

Clinical Interest:

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus
• Insulin Pump therapy in Diabetes
• Gestational Diabetes
• Diabetic Foot and Diabetic Neuropathy.

Research Interest:

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus
• Insulin Pump therapy in Diabetes
• Gestational Diabetes
• Diabetic Foot
• Diabetic Neuropathy and Angiopathy
• Study of hypoglycaemia using brain neuroimaging techniques (PET scan, fMRI).

• Awarded the Albert Renold Fellowship by the European Foundation for the Study of Diabetes supported by an educational grant from Merck Sharp & Dohme (MSD) (2009)

• Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours. Nikou GC, Marinou K, Thomakos P, Papageorgiou D, Sanzanidis V, Nikolaou P, Kosmidis C, Moulakakis A, Mallas E. Pancreatology. 2008;8(4-5):510-9.
• Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Fatouros IG, Chatzinikolaou A, Tournis S, Nikolaidis MG, Jamurtas AZ, Douroudos II, Papassotiriou I, Thomakos P, Taxildaris K, Mastorakos G, Mi-trakou A. Diabetes Care. 2009 Dec;32(12):2161-7. 
• Trends in the management of type 2 diabetes and its prescription drug costs in Greece (1998 & 2006). Liatis S, Thomakos P, Papaoikonomou S, Papazafeiropoulou A, Giannakopoulos N, Ka-ragiaouri E, Sotiropoulos A, Bousboulas S, Melidonis A, Pappas S, Katsilambros N. Exp Clin En-docrinol Diabetes. 2009 Oct;117(9):505-10.
• The effect of modafinil on counterregulatory and cognitive responses to experimental hypogly-caemia in type 1 diabetic patients with hypoglycaemia unawareness. P Thomakos, MM Teh, Y Samarasighe, A Pernet, B Wilson, P Choudhary, SA Amiel. Diabetologia 2010;53: (S1):238.
• Cigarette Smoking Is Associated with Prolongation of the QTc Interval Duration in Patients with Type 2 Diabetes Mellitus. Thomakos P, Liatis S, Kalopita S, Vlahodimitris I, Stathi C, Katsilambros N, Tentolouris N, Makrilakis K. Int J Endocrinol. 2013;2013:329189.
• Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes. Kalopita S, Liatis S, Thomakos P, Vlahodimitris I, Stathi C, Katsilambros N, Tentolouris N, Makrilakis K. J Diabetes Res. 2014;2014:835392.
• Do Sulfonylureas Preserve Cortical Function during Hypoglycemia in Patients with Type 1 Diabe-tes and Hypoglycemia Unawareness? P Thomakos, A Finlayson, A Pernet, B Wilson, SA Amiel, P Choudhary. Diabetes. 2015;64(S1):A91 
• Pump users and insulin infusion sets during financial crisis: A matter of consideration? P. Thomakos, O. Kepaptsoglou, I. Taraoune, C. Barreto, C. Zoupas. Diabetes Technology & Therapeutics. February 2015, 17(S1):A69.
• Which factors may affect the quality of life in patients with Type 1 Diabetes Mellitus using Con-tinuous Subcutaneous Insulin Infusion pumps? P. Thomakos, A. Mitrakou, O. Kepaptsoglou, I. Taraoune, C. Barreto, A. Pappas, C. Zoupas. Diabetes Technology & Therapeutics. February 2016, 18(S1):A113-114.
• Which factors may affect pregnancy outcomes in In Vitro Fertilization pregnancies complicated by Gestational Diabetes Mellitus? Thomakos P, Kepaptsoglou O, Taraoune I, Barreto C, Ko-rantzis A, Trouvas D, Pantos A, Pantos K, Mastrominas M, Zoupas Ch. Diabetes. 2016; 65(S1):A358